CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Visual Examination Frequency for People Taking Ethambutol for Tuberculosis: Guidelines

Last updated: June 29, 2020
Project Number: RB1496-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What are the evidence-based guidelines regarding the frequency of visual examination for people taking ethambutol as part of a tuberculosis treatment regimen?

Key Message

Five evidence-based guidelines were identified regarding the frequency of visual examination for people taking ethambutol as part of a tuberculosis treatment regimen.